General Practice · Arecibo, PR
NPI
1427091040
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
Carretera Num. 2 Ramal 638 Km. 6.0 Miraflores, 638 Km. 6.0
Arecibo, PR, 00612
Phone (787) 815-2693
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
3,590 prescriptions
Company payments, 2025
$445
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Salvador Lopez-Rojas prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 162 prescriptions and refills. In total Salvador Lopez-Rojas wrote 3,590 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Synthroid Levothyroxine Sodium | 162 | 286 | 32 | $14K |
| Simvastatin Generic | 153 | 299 | 32 | $1,136 |
| Rosuvastatin Calcium Generic | 122 | 196 | 29 | $1,263 |
| Losartan Potassium Generic | 118 | 220 | 24 | $1,064 |
| Descovy Emtricitabine/Tenofov Alafenam | 99 | 99 | 18 | $220K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 93 | 93 | 13 | $347K |
| Gabapentin Generic | 91 | 145 | 22 | $1,054 |
| Lisinopril Generic | 85 | 165 | 16 | $479 |
| Atorvastatin Calcium Generic | 81 | 139 | 18 | $615 |
| Omeprazole Generic | 80 | 116 | 19 | $562 |
| Metformin Hcl Generic | 79 | 147 | 15 | $555 |
| Glimepiride Generic | 79 | 157 | 18 | $760 |
| Fenofibrate Fenofibrate Nanocrystallized | 69 | 103 | 17 | $1,237 |
| Montelukast Sodium Generic | 54 | 80 | 14 | $475 |
| Tivicay Dolutegravir Sodium | 53 | 53 | 13 | $123K |
Brand drugs: 911 claims; generic drugs: 2,659 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Salvador Lopez-Rojas $445 ($445 in general payments such as food, travel and fees) from 4 companies. The largest payer was Gilead Sciences, Inc. with $291.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.